Any stock, in context
MARKSANS · Healthcare
Marksans Pharma Ltd.
Observation · 15 Oct 2026
How these are readMarksans Pharma closed at ₹307.9 on 15 Oct 2026, 32.3% above its 200-day average and 3.5% below its 50-day average: above the long line, below the short one. It sits 11.4% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 15.6%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +32.3%
- the long line
- vs 50-day
- −3.5%
- the short line
- From 52w high
- −11.4%
- ₹155.0₹351.0
- 3 months
- +15.6%
- sector median −2.7% · 25 of 146
Nifty Microcap 250 · Healthcare · EQ series · median traded value ₹54 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −2.01%
- 1W
- –
- 1M
- −1.60%
- 3M
- +15.58%
- YTD
- –
- 1Y
- +70.83%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.